Breakthrough treatment after years of only modest progress in heart failure

+Print Archive
South GP CME

Breakthrough treatment after years of only modest progress in heart failure

Joan Leighton and Gerry Devlin
Heart Foundation GP liaison Joan Leighton and medical director Gerry Devlin see promise in new heart-failure drug Entresto
Entresto is not a ‘flash in the pan’ but a genuine breakthrough. In time, it will become a standard treatment for heart failure A new drug for he
References

1. McMurray JV, Packer M, Desai AS, et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993–1004.

2. Taylor CJ, Ordóñez-Mena JM, Roalfe AK, et al. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study. BMJ 2019;364:l223 (on­line 13 February).